Boston Scientific Corp. (BSX)

Going to be giving this one a very optimistic forecast over the winter. Profit last quarter would have been up considerably had they not had to pay out the settlement - now that that's over and accounted for it's looking less bleak.

extreme oversold condition prevalent and when Obies one kenobie's healthcare agenda is exhausted BSX wll trade well north of present price

Mmm...medical devices...

Pick on a dip

Watching stock, dipping and now buying with real cash ;)

Been watching this stock for awhile and felt it was somewhat overpriced. I think now would be a decent entry point so long as it stays below $9.

With Canada opening up to the new additions to the boston's arsonal, they may do well stand alone or be a viable candadite for a takeover.

Cost cutting measures completed and ready to run.

Insider buying: Officer just bought $1 million worth @ $11/share.

Simply growth and value

They are generating lots of cash and rapidly paying down debt. Insider selling last fall was induced by the financial crisis and does not reflect a lack of faith in the business. Gross margin of 70%. They will likely benefit from universal health care as they will make up on volume any reduction in prices imposed by the new regime.

great free cash flow, should benefit from health care reform and they are paying down debt over time. Heavily owned by John Paulson

Over the last one year management has aggressively moved to cut costs and fix a number of issues resulting in a business with a much improved operating, strategic and financial profile. Fortunately for us these improvements have not yet been reflected in the Company’s stock price.

Buy good companies when they are out of favor. Especially when they are trading at depressed values. This one has gone through the blender since the GDT acquisition but I suspect that the growing pains are being worked out. The company makes a wide variety of essential medical products that are in demand and will continue to be. They are profitable and earnings should continue to improve going forward. Heck, GDT was on JNJ's radar for about 24 billion. Right now, BSX (which acquired GDT) looks to only have a market cap of around 11 billion so who knows, they may be a takeover target of some sort as well. Either way, I see this stock going up on its own or through possible merger in the future. This appears to be a good entry point on a company that's been down but gearing up to bounce back in the future.

Stock is greatly undervalued at the moment. When selloff by founders ends, I think this stock will return to its real value of low double digits. Current selloff is reported to be a result of margin calls, and that being exacerbated by a downturn in the economy.

Undervalued and the price is definitely right at $6.14.

way undervalued

Margin calls forced owner to sell.

Great stock for years to come